An observational study in Acute Respiratory Distress Syndrome and Mechanical Ventilation, sponsored by Southeast University, China. Recruiting at 1 site in China. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2025-11-26.
Sponsored by Southeast University, China · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Respiratory Distress Syndrome by Southeast University, China — 10 open to participants now, 10 under way, 2 of them phase 3. Respiratory Distress Syndrome · Southeast University, China.
Among the 24 studies in Respiratory Distress Syndrome by Southeast University, China, this one is the 8th largest by planned enrollment of the 13 observational ones that give a count, is one of 2 that started in 2025, is one of 13 observational ones, and was the 18th registered.
1,389 studies on the registry are indexed under Respiratory Distress Syndrome; 281 are open to participants now.
Browse Respiratory Distress Syndrome studies →10 of the 24 studies in Respiratory Distress Syndrome by Southeast University, China are open now, in 1 country. Recruiting first, the newest first:
Southeast University, China · Sites in China
Southeast University, China · Sites in China
Ages 18+
Southeast University, China · Sites in China
Ages 18+
Southeast University, China · Sites in China
Ages 18+
Southeast University, China · Sites in China
Ages 18+
By country, each count listing its studies:
Of the 196 Respiratory Distress Syndrome studies recruiting now, 116 (59%) set no upper age limit and 50 (26%) stop at 75 or younger; 52 take children under 18; 9 take healthy volunteers.
This study: 19 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 100 across 476 observational studies indexed under Respiratory Distress Syndrome.
Median enrollment 93 across the 11 interventional studies, 134 across the 13 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Southeast University, China is the lead sponsor of 169 studies on the registry; 46 are open to participants now.
3 of the studies in Respiratory Distress Syndrome by Southeast University, China that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07528196Phase 3Southeast University, ChinaStudy of Xuanbai Shengmai Decoction in the Treatment of Acute Respiratory Distress Syndrome | 2027-06 |
| NCT07289711Southeast University, ChinaValidation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study | 2026-12-31 |
| NCT06919484Southeast University, ChinaThe Physiological Effect of RCexp on Ventilation/Perfusion Distribution | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 24 studies in Respiratory Distress Syndrome by Southeast University, China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
With the exception of setting the positive end-expiratory pressure (PEEP), the expiratory phase is commonly overlooked during MV. The expiratory time constant (RCexp) plays an important role in understanding the mechanical properties of the respiratory system in patients receiving mechanical ventilation. However, it is unclear that the effect of expiratory time constant on the ventilation and perfusion distribution.
With the exception of setting the positive end-expiratory pressure (PEEP), the expiratory phase is commonly overlooked during MV. The expiratory time constant (RCexp) plays an important role in understanding the mechanical properties of the respiratory system in patients receiving mechanical ventilation. However, it is unclear that the effect of expiratory time constant on the ventilation and perfusion distribution.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
adult patients with ARDS receiving mechanical ventilation no more than 72 hours
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: RCexp
patients received different RCexp
Difference in ventilation/perfusion mismatch
ventilation/perfusion mismatch is measured by EIT
Time frame: 4 hours
Difference in dead space
dead space is measured by EIT
Time frame: 4 hours
Difference in shunt
shunt is measured by EIT
Time frame: 4 hours
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2025; primary completion for Dec 2026, 13 months later.
Of 228 non-industry observational studies under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 13 months is below that.
Counting every sponsor, half of 234 studies reached it within 24 months; a quarter within 12 and three quarters within 49.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome →